Profil
Sarah Middleton is the founder of Haemostatix Ltd.
She previously worked as a Project Director at Andaris Group and as a Principal at Delta Biotechnology Ltd.
Postes actifs de Sarah Middleton
| Sociétés | Poste | Début |
|---|---|---|
Haemostatix Ltd.
 Haemostatix Ltd. Pharmaceuticals: MajorHealth Technology Haemostatix Ltd. designs and develops solutions for haemostasis and thrombosis. Its products include Rapid and effective haemostatic action which is new class of topical coagulant or haemostat that is applied directly to a wound during surgery to control bleeding, and ready-to-use formulations, blood-free ingredients and a new class with a unique mode of action. The company was founded by Sarah Middleton and Alison Goodall in 2003 and is headquartered in Nottingham, the United Kingdom. | Fondateur | 01/01/2003 |
Anciens postes connus de Sarah Middleton
| Sociétés | Poste | Fin |
|---|---|---|
Andaris Group
 Andaris Group Miscellaneous Commercial ServicesCommercial Services Part of Perrigo Co. Plc, Andaris Group is a British company that researches and develops physical, engineering, and life sciences. The company is based in Ruddington, UK. Andaris Group was acquired by Quadrant Healthcare Plc, part of Perrigo Co. Plc from January 11, 2001 on November 05, 1998 for $22.04 million. | Corporate Officer/Principal | - |
Delta Biotechnology Ltd.
 Delta Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Part of Novonesis A/S, Delta Biotechnology Ltd. is a British company that produces and markets a range of valuable proteins from yeast using low-cost manufacturing technologies. The company is based in Windlesham, UK. Delta Biotechnology was acquired by Novozymes A/S on July 06, 2006. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Haemostatix Ltd.
Haemostatix Ltd. Pharmaceuticals: MajorHealth Technology Haemostatix Ltd. designs and develops solutions for haemostasis and thrombosis. Its products include Rapid and effective haemostatic action which is new class of topical coagulant or haemostat that is applied directly to a wound during surgery to control bleeding, and ready-to-use formulations, blood-free ingredients and a new class with a unique mode of action. The company was founded by Sarah Middleton and Alison Goodall in 2003 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
Delta Biotechnology Ltd.
Delta Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Part of Novonesis A/S, Delta Biotechnology Ltd. is a British company that produces and markets a range of valuable proteins from yeast using low-cost manufacturing technologies. The company is based in Windlesham, UK. Delta Biotechnology was acquired by Novozymes A/S on July 06, 2006. | Health Technology |
Andaris Group
Andaris Group Miscellaneous Commercial ServicesCommercial Services Part of Perrigo Co. Plc, Andaris Group is a British company that researches and develops physical, engineering, and life sciences. The company is based in Ruddington, UK. Andaris Group was acquired by Quadrant Healthcare Plc, part of Perrigo Co. Plc from January 11, 2001 on November 05, 1998 for $22.04 million. | Commercial Services |
